| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
40,211 | 18,666 | 26,391 | 34,164 | 59,077 |
| Cost of Revenue
|
-943 | -303 | 0 | -- | -- |
|
Gross Profit
|
39,268 | 18,363 | 26,391 | -- | -- |
| Selling, General and Administrative Expenses
|
-27,355 | -29,215 | -30,741 | -33,313 | -24,903 |
|
Research and Development Expenses
|
-42,688 | -47,754 | -55,110 | -56,525 | -48,364 |
| Depreciation, Amortization and Depletion
|
-15,362 | -12,912 | -17,407 | -13,554 | -13,050 |
|
Other Income/Expense, Operating
|
-463 | 2,549 | 2,365 | -191 | 592 |
|
Operating Income/Expenses
|
-85,868 | -87,332 | -100,893 | -103,583 | -85,725 |
|
Total Operating Profit/Loss
|
-46,600 | -68,969 | -74,502 | -69,419 | -26,648 |
| Total Net Finance Income/Expense
|
2,670 | 2,660 | 3,106 | 5,055 | 587 |
| Irregular Income/Expenses
|
3,000 | -- | -- | -- | -- |
|
Other Income/Expense, Non-Operating
|
52 | 15 | -15 | 1 | 0 |
|
Non-Operating Income/Expenses, Total
|
2,722 | 2,675 | 3,091 | 5,056 | 587 |
|
Pretax Income
|
-43,878 | -66,294 | -71,411 | -64,363 | -26,061 |
|
Provision for Income Tax
|
405 | 1,515 | 9,378 | 13,744 | 3,727 |
|
Net Income from Continuing Operations
|
-43,473 | -64,779 | -62,033 | -50,619 | -22,334 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-43,473 | -64,779 | -62,033 | -50,619 | -22,334 |
|
Net Income after Non-Controlling/Minority Interests
|
-43,473 | -64,779 | -62,033 | -50,619 | -22,334 |
|
Net Income Available to Common Stockholders
|
-43,473 | -64,779 | -62,033 | -50,619 | -22,334 |
|
Diluted Net Income Available to Common Stockholders
|
-43,473 | -64,779 | -62,033 | -50,619 | -22,334 |
| Basic EPS
|
-0.34 | -0.57 | -0.61 | -0.51 | -0.26 |
| Diluted EPS
|
-0.34 | -0.57 | -0.61 | -0.51 | -0.26 |
|
Basic Weighted Average Shares Outstanding
|
128,572.75 | 113,635 | 102,365 | 99,683 | 85,318 |
|
Diluted Weighted Average Shares Outstanding
|
128,572.75 | 113,635 | 102,365 | 99,683 | 85,318 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-46,548 | -68,954 | -74,517 | -69,418 | -26,648 |
|
EBITDA
|
-23,202 | -47,200 | -50,934 | -49,921 | -8,399 |
|
Normalized EBITDA
|
-10,039 | -34,376 | -29,435 | -25,101 | 9,923 |
|
Normalized Income
|
-30,431.49 | -52,249.95 | -43,350.37 | -31,110.48 | -6,632.05 |
|
Total Unusual Items
|
13,163 | 12,824 | 21,499 | 24,820 | 18,322 |
12/31/2022 - 9/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade